BioSenic S.A. / Fundamentals
Income statement
- Net revenue
€3.20M - Cost of goods sold
€367.00K - Gross profit
€2.83M - SG&A expenses
€6.38M - R&D expenses
€6.14M - EBITDA
-€24.97M - D&A
€404.00K - EBIT
-€9.71M - Interest expenses
€10.77M - EBT
-€31.20M - Tax expenses
-€294.00K - Net income
-€29.80M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€22.67M - Changes in working capital
€514.50K - Operating cash flow
-€5.98M - Capex
€6.00K - Other investing cash flow
€5.00K - Net investing cash flow
€1.96M - Total cash dividends paid
€0.00 - Issuance of common stock
€3.05M - Debt repayment
€1.49M - Other financing cash flow
€2.23M - Net financing cash flow
€4.48M - Foreign exchange effects
-€2.12M - Net change in cash
-€2.41M - Cash at end of period
€816.00K - Free cash flow
-€5.97M
Balance sheet
- Cash and cash equivalents
€816.00K - Cash and short-term investments
€816.00K - Total receivables
€1.34M - Inventory
€0.00 - Other current assets
€1.50M - Total current assets
€2.59M - Property, plant & equipment
€591.00K - Goodwill
€0.00 - Intangible assets
€2.98M - Long-term investments
€12.00K - Other non-current assets
€376.00K - Total non-current assets
€6.81M - Total assets
€9.40M - Accounts payable
€2.60M - Short-term debt
€3.56M - Other current liabilities
€322.00K - Total current liabilities
€6.49M - Long-term debt
€23.23M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€81.00K - Total non-current liabilities
€23.31M - Total liabilities
€29.80M - Common stock
€8.18M - Retained earnings
-€34.40M - Other equity
-€83.00K - Total equity
-€20.40M - Total liabilities and shareholders' equity
€9.40M
Company information
- Market capitalization
€1.50M - Employees
12 - Enterprise Value
€27.48M
Company ratios
- Gross margin
-
88.5% Much better than peer group: -368.7% - EBITDA margin
-
-781.3% Much better than peer group: -15,198.5% - EBIT margin
-
-304.0% Much better than peer group: -23,337.1% - EBT margin
-
-976.4% Much better than peer group: -15,093.5% - Net margin
-
-932.5% Much better than peer group: -14,666.4% - ROE
-
146.0% Much worse than peer group: 842.6% - ROA
-
-317.1% Much worse than peer group: -60.4% - Asset turnover
-
34.0% Better than peer group: 24.8% - FCF margin
-
-187.2% Much better than peer group: -25,587.7% - FCF yield
-398.4% - Efficiency ratio
881.3% - Net sales per employee
-
€266.29K - Net income per employee
-
-€2.48M